| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |